Literature DB >> 9763077

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

M C Hall1, S Womack, A I Sagalowsky, T Carmody, M D Erickstad, C G Roehrborn.   

Abstract

OBJECTIVES: To review a large single-center experience of patients treated for upper tract transitional cell carcinoma (TCC) with extended follow-up in order to identify patterns of recurrence, assess patient outcomes, and determine the impact of traditional prognostic factors.
METHODS: We reviewed 252 patients treated surgically for upper tract TCC with a median follow-up of 64 months. Most patients (77%) underwent nephroureterectomy, whereas 17% were treated with a parenchymal sparing approach. Traditional prognostic factors including age, sex, tumor stage, grade, location, and type of surgical treatment were analyzed with respect to disease recurrence and survival.
RESULTS: Disease relapse occurred in 67 patients (27%) at a median time of 12.0 months. Recurrences were local in the retroperitoneum (9%), the bladder (51%), remaining upper tract (18%), or distant in the lung, bone, or liver (22%). The 6 patients with local relapse were among the 73 patients with pT3 or pT4 tumors, and all died of TCC at a median time from diagnosis of 37 months. Significant prognostic factors for recurrence by univariate analysis were tumor grade (P = 0.0014) and stage (P = 0.0001). On multivariate analysis, only tumor stage (P = 0.017) and treatment modality (P = 0.020) were predictors of recurrence. Actuarial 5-year disease-specific survival rates by primary tumor stage were 100% for Ta/cis, 91.7% for T1, 72.6% for T2, and 40.5% for T3. Patients with primary Stage T4 tumors had a median survival of 6 months. Although tumor stage and grade correlated with disease-specific survival on univariate analysis, only patient age (P = 0.042) and stage (P = 0.0001) were significant on multivariate analysis with the type of surgical procedure performed approaching significance (P = 0.0504).
CONCLUSIONS: Primary tumor stage and surgical procedure performed (radical versus parenchymal sparing) are important predictors of disease recurrence. Patient age and tumor stage were the only predictors of disease-specific survival on multivariate analysis with the type of surgical procedure approaching significance. Radical nephroureterectomy achieves excellent local control even in the setting of locally advanced (pT3 or T4) disease. The major clinical feature in this setting is distant failure, and the development of effective systemic therapy is needed to improve the outcome in these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9763077     DOI: 10.1016/s0090-4295(98)00295-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  163 in total

1.  Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.

Authors:  Ricardo L Favaretto; Shahrokh F Shariat; Caroline Savage; Guilherme Godoy; Daher C Chade; Matthew Kaag; Bernard H Bochner; Jonathan Coleman; Guido Dalbagni
Journal:  BJU Int       Date:  2011-06-01       Impact factor: 5.588

2.  Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?

Authors:  Ricardo L Favaretto; Shahrokh F Shariat; Daher C Chade; Guilherme Godoy; Matthew Kaag; Angel M Cronin; Bernard H Bochner; Jonathan Coleman; Guido Dalbagni
Journal:  Eur Urol       Date:  2010-08-11       Impact factor: 20.096

3.  Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients.

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Diaa Eldin Taha; Samer El-Halwagy
Journal:  Turk J Urol       Date:  2018-03-06

Review 4.  Imaging of Solid Renal Masses.

Authors:  Fernando U Kay; Ivan Pedrosa
Journal:  Urol Clin North Am       Date:  2018-06-15       Impact factor: 2.241

5.  Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

Authors:  Eiji Kikuchi; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Shuji Mikami; Yair Lotan; Mesut Remzi; Christian Bolenz; Cord Langner; Alon Weizer; Francesco Montorsi; Karim Bensalah; Theresa M Koppie; Mario I Fernández; Jay D Raman; Wassim Kassouf; Christopher G Wood; Nazareno Suardi; Mototsugu Oya; Shahrokh F Shariat
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

6.  Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy.

Authors:  Sophie Hurel; Morgan Rouprêt; Thomas Seisen; Eva Comperat; Véronique Phé; Stéphane Droupy; François Audenet; Géraldine Pignot; Xavier Cathelineau; Laurent Guy; Olivier Cussenot; Adil Ouzzane; Gregory Bozzini; Laurent Nison; Alain Ruffion; Pierre Colin
Journal:  World J Urol       Date:  2014-05-09       Impact factor: 4.226

7.  HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.

Authors:  Yuka Sasaki; Takeshi Sasaki; Taketo Kawai; Teppei Morikawa; Keisuke Matsusaka; Akiko Kunita; Haruki Kume; Ichiro Aoki; Yukio Homma; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

8.  Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Authors:  Shuichi Morizane; Hideto Iwamoto; Toshihiko Masago; Akihisa Yao; Tadahiro Isoyama; Takehiro Sejima; Atsushi Takenaka
Journal:  Int Urol Nephrol       Date:  2012-12-11       Impact factor: 2.370

Review 9.  [Endosopic organ-sparing treatment of urothelial tumors of the upper urinary tract: indications and results].

Authors:  M Hruza; C Stock; D Teber; J J Rassweiler
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

10.  Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report.

Authors:  Soichiro Yoshida; Shuichiro Kobayashi; Fumitaka Koga; Junichiro Ishioka; Chikako Ishii; Hiroshi Tanaka; Yasukazu Nakanishi; Yoh Matsuoka; Noboru Numao; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Kazunori Kihara
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.